Drug Approval | May 06, 2024
Dr. Reddy's Laboratories launches Doxycycline Capsules, 40 mg in US
ORACEA is a trademark of Galderma Holdings, S.A.
ORACEA is a trademark of Galderma Holdings, S.A.
New data for Tezspire and Breztri demonstrate AstraZeneca’s innovation and commitment to transform care in COPD
New advanced technology-enabled offering aims to streamline synthetic route identification for novel active pharmaceutical ingredients (APIs)
Parexel will leverage Palantir’s Foundry and Artificial Intelligence Platform to further power its clinical data platform
The QC Lab is equipped with advanced instruments to ensure rigorous quality control across all manufacturing processes
The proposed facility is expected to be operational around January, 2027
The US Generics market has been witnessing significant pricing pressure leading to significant losses at Jubilant Cadista since FY2022 onwards.
Around 7% of the Indian population suffers from IBS
Longest survival follow-up ever reported for immunotherapy treatment in this setting
The companies also plan to collaborate on several early pipeline projects, further technology exploration, and engineering of scalable manufacturing solutions across Novo Nordisk's portfolio
Subscribe To Our Newsletter & Stay Updated
